Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer.

Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Hardy D, Chan W, Burau K.

Cancer. 2009 Nov 15;115(22):5296-308. doi: 10.1002/cncr.24621. Erratum in: Cancer. 2009 Dec 15;115(24):5849-51.

2.

Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer.

Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH.

J Clin Oncol. 2007 Sep 1;25(25):3808-15.

PMID:
17664460
3.

Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998-2005.

Du XL, Xia R, Burau K, Liu CC.

Med Oncol. 2011 Dec;28 Suppl 1:S80-90. doi: 10.1007/s12032-010-9717-7.

PMID:
20967512
4.

Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.

Doyle JJ, Neugut AI, Jacobson JS, Grann VR, Hershman DL.

J Clin Oncol. 2005 Dec 1;23(34):8597-605.

PMID:
16314622
5.

Cardioprotective effect of dexrazoxane in patients with breast cancer treated with anthracyclines in adjuvant setting: a 10-year single institution experience.

Testore F, Milanese S, Ceste M, de Conciliis E, Parello G, Lanfranco C, Manfredi R, Ferrero G, Simoni C, Miglietta L, Ferro S, Giaretto L, Bosso G.

Am J Cardiovasc Drugs. 2008;8(4):257-63.

PMID:
18690759
6.

Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.

Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW, van Leeuwen FE.

J Natl Cancer Inst. 2007 Mar 7;99(5):365-75.

PMID:
17341728
7.

Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer.

Hurria A, Hurria A, Brogan K, Panageas KS, Pearce C, Norton L, Jakubowski A, Howard J, Hudis C.

Drugs Aging. 2005;22(9):785-91.

PMID:
16156682
8.

New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.

Ryberg M, Nielsen D, Cortese G, Nielsen G, Skovsgaard T, Andersen PK.

J Natl Cancer Inst. 2008 Aug 6;100(15):1058-67. doi: 10.1093/jnci/djn206.

PMID:
18664656
9.

Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.

Jensen BV.

Semin Oncol. 2006 Jun;33(3 Suppl 8):S15-21. Review.

PMID:
16781285
10.

Cardiac mortality in patients with stage I and II diffuse large B-cell lymphoma treated with and without radiation: a surveillance, epidemiology, and end-results analysis.

Pugh TJ, Ballonoff A, Rusthoven KE, McCammon R, Kavanagh B, Newman F, Rabinovitch R.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):845-9. doi: 10.1016/j.ijrobp.2009.02.045.

PMID:
19515509
11.

Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk.

Patt DA, Duan Z, Fang S, Hortobagyi GN, Giordano SH.

J Clin Oncol. 2007 Sep 1;25(25):3871-6.

PMID:
17664457
12.

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR.

J Natl Cancer Inst. 2007 Feb 7;99(3):196-205.

PMID:
17284714
14.

Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.

Le Deley MC, Suzan F, Cutuli B, Delaloge S, Shamsaldin A, Linassier C, Clisant S, de Vathaire F, Fenaux P, Hill C.

J Clin Oncol. 2007 Jan 20;25(3):292-300.

PMID:
17159192
15.

Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy.

Baxter NN, Durham SB, Phillips KA, Habermann EB, Virning BA.

J Am Geriatr Soc. 2009 Mar;57(3):403-11. doi: 10.1111/j.1532-5415.2008.02130.x.

PMID:
19278395
16.

Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.

Hurria A, Brogan K, Panageas KS, Pearce C, Norton L, Jakubowski A, Zauderer M, Howard J, Hudis C.

Breast Cancer Res Treat. 2005 Jul;92(2):151-6.

PMID:
15986124
17.

Cardiotoxicity and cardioprotection during chemotherapy.

Hochster H, Wasserheit C, Speyer J.

Curr Opin Oncol. 1995 Jul;7(4):304-9. Review.

PMID:
7578376
18.

Cardiac morbidity of adjuvant radiotherapy for breast cancer.

Patt DA, Goodwin JS, Kuo YF, Freeman JL, Zhang DD, Buchholz TA, Hortobagyi GN, Giordano SH.

J Clin Oncol. 2005 Oct 20;23(30):7475-82.

PMID:
16157933
20.

Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer.

Nurgalieva Z, Liu CC, Du XL.

Med Oncol. 2011 Sep;28(3):716-25. doi: 10.1007/s12032-010-9512-5.

PMID:
20361359
Items per page

Supplemental Content

Support Center